Feature
An ongoing systematic review :
Stem cells as a potential therapy in managing various disorders of metabolic syndrome
problems . Each stem-cell are cultivated differently and specifically for each disease . Be it for aging , heart disease , stroke or aesthetic use in general , the technique of cultivation would differ . The fundamental knowledge and the method of cultivation by a stemcell specialist and the lab is pivotal ” says Professor Dr Chua Kiến Hụi , the Executive Director ( R & D ) for Supergenics Berhad , medical advisor for Wellspring Solution Sdn Bhd and lecturer of Regenerative Medicine at University Kebangsaan Malaysia .
Prof Chua further explained that the use of stemcell as a repair agent is to increase the metabolic rate of a patient . A specific number of stem cells can gradually influence the entire fat tissue , resulting in significant positive effects of reducing its volume ; provide a supply of stem cells to activate weight loss and to boost one ’ s immunomodulation .
The dosage for the therapy should be determined by a professional , two groups of people to be exact - the stem-cell specialist , who will determine what type of stem-cell to be used and second , the clinician who will draw the dosage and perform the procedures .
Stem cells as the alternative for autoimmune disease
“ One stemcell cannot and will not eliminate all problems . Each stem-cell are cultivated differently and specifically for each disease .
With the transformation of modern lifestyles and population ageing , obesity has become a global epidemic , as one of the important threat to human health of chronic non-communicable diseases ( NCD ). Stem cell therapy seems promising as an alternative strategy for managing obesity and related metabolic problems . Adipose tissue-derived stem cells ( ADSCs ) and umbilical cord mesenchymal stem cells ( UCMSCs ) have received widespread attention , which provides new ideas for the treatment of obesity and various metabolic-related diseases , due to their abundant reserves , easy acquisition , rapid expansion , and multi-directional differentiation potential , low immunogenicity and many other advantages .
In the past half century , scientific research has attempted to adopt a variety of measures to control obesity and its related metabolic diseases . However , all these treatment measures have certain limitations , so there is an urgent need to introduce new intervention programs to implement them . In this context , stem cell therapy sprouted in response to the needs of the times .
“ One stem-cell cannot and will not eliminate all
MSCs and MetS - the study Among all stem cells , mesenchymal stem cells ( MSCs ) are attractive candidate due to their vital role in adipogenesis and are proposed as new type of treatment option . MSCs are the most studied and defined stem cells , and the cells originating from the mesoderm are called progenitor cells in the traditional sense , and have the potential for self-renewal and multi-directional differentiation , such as differentiation into bone , fat , and chondrocytes . Adipose tissue-derived stem cells ( ADSCs ) possess the characteristics of easy access , rapid proliferation in vitro and autologous transplantation . In the past nearly two decades , the use of adipose tissue progenitor cells as therapeutic agents has greatly increased , becoming the first choice for clinical regenerative medicine and even aesthetic medicine , and stimulating the development of new research fields and industries around the world .
Amongst the research brains leading the study between MSCs and MetS are the team from Centre for Tissue Engineering and Regenerative Medicine , and Department of Physiology , Faculty of Medicine , Universiti Kebangsaan Malaysia . This is an ongoing study with aim to continuously find new solutions to existing medical or drugs treatment .
The team further indicated that MSCs have been credited as a good choice that has a potential effect on the management of multiple MetS clusters , supported by the favourable outcomes
54 ISSUE 6 | 2024 GlobalHealthAsiaPacific . com